Sangamo BioSciences, Inc. Provides Clinical Update On SB-728-T Program And Progress In Other ZFP Applications At Annual Meeting Of The American Society Of Gene And Cell Therapy /PRNewswire/ -- Sangamo BioSciences, Inc. announced that data from clinical, preclinical and research-stage programs focused on the development of ZFP TherapeuticsA were ... (more)
http://ift.tt/TQTTzJ
http://ift.tt/TQTTzJ
No comments:
Post a Comment